Navigation Links
Haemonetics Reports Third Quarter of Fiscal 11
Date:1/31/2011

operating income$81,654$79,184Restructuring, deal integration and closing costs6,598450Contingent consideration income(1,894)-Non-GAAP operating income $86,358$79,634Non-GAAP income before taxesGAAP income before taxes$81,510$77,382Restructuring, deal integration and closing costs6,598450Contingent consideration income(1,894)-Non-GAAP income before taxes$86,214$77,832Non-GAAP net incomeGAAP net income$58,992$54,409Restructuring, deal integration and closing costs6,598450Contingent consideration income(1,894)-Tax benefit associated with non-GAAP items(1,939)(110)Non-GAAP net income$61,757$54,749Non-GAAP net income per common share assuming dilutionGAAP net income per common share assuming dilution$2.32$2.08Non-GAAP items after tax per common share assuming dilution$0.11$0.02Non-GAAP net income per common share assuming dilution$2.42$2.10Presented below are additional Constant Currency performance measures.  We measure different components of our business at constant currency.  We believe this information is useful for investors because it allows for an evaluation of the Company without the effect of changes in foreign exchange rates.  These results convert our local foreign currency operating results to the US Dollar at constant exchange rates of $1.20 per Euro, and 110 Yen to the $1.00.  They also exclude the results of our foreign currency hedging program described in Note 7 to our consolidated financial statements in our Form 10-K.  Non-GAAP revenuesGAAP revenue$506,661$476,326Foreign currency effects(29,788)(30,481)Non-GAAP revenue - constant currency$476,873$445,845Non-GAAP net incomeNon-GAAP net income, adjusted for restructuring and deal integration costs and contingent consideration income$61,757$54,749Foreign currency effects(12,589)(15,711)Income tax associated with foreign currency effects3,5764,798Non-GAAP net income - constant currency52,74443,836Non-GAAP net income per common share assuming dilutionNon-GAAP net income per commo
'/>"/>
SOURCE Haemonetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Haemonetics Receives Favorable Ruling in Patent Lawsuit against Competitive Technology
2. Neogen Reports 33% Increase in Net Income
3. Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
4. New Topical Patent Research Reports Recently Published at MarketPublishers.com
5. YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387
6. Oncothyreon Reports Positive Data from Phase 1 Clinical Trial of PI3-Kinase Inhibitor PX-866 in Patients with Relapsed or Refractory Solid Tumors
7. GeneLink Reports Third Quarter Results
8. Imagenetix, Inc. Reports Second Quarter 2011 Results
9. Transgenomic Reports Third Quarter Financial Results
10. Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... -- Research and Markets has announced the ... 2014" report to their offering. ... professional and in-depth study on the current state of ... provides a basic overview of the industry including definitions, ... market analysis is provided for the international markets including ...
(Date:9/18/2014)... Leatherwood Plastics has selected Vycom’s Flametec ... competitive in the semiconductor, clean room and medical ... product quality and productivity, according to Dwight Leatherwood, ... 1980 in Lewisville, TX, Leatherwood Plastics ... the business. Much of Leatherwood’s equipment building relies ...
(Date:9/18/2014)... -- MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology ... cancer, announced today that Daniel P. Gold , Ph.D., ... NewsMakers in the Biotech Industry conference on Friday, September ... Broadway Hotel & Conference Center in New York ... accessed at www.meipharma.com . A replay will be available ...
(Date:9/18/2014)... 18, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ... concurrent but separate underwritten offerings of 10,000,000 shares of ... of $2.00 per share, for expected gross proceeds of ... Convertible Preferred Stock at a price to the public ... $20 million. Each share of Series A Convertible Preferred ...
Breaking Biology Technology:Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3
... Swedish environmental technology,company SEKAB has signed an agreement ... with LDC Bioenergia, a Brazilian ethanol,and sugar industry ... Dreyfus., "The agreement safeguards supplies of additional ... for environmental and social,sustainability," says Anders Fredriksson, Executive ...
... ARGONNE, Ill. (July 17, 2008) Researchers at the U.S. ... industrial partners have won two R&D 100 Awards for ... scientists have been awarded 101 R&D 100 Awards since ... a prestigious R&D 100 Award -- dubbed the "Oscars ...
... Calif., July 17 In conjunction with,CorVel Corporation,s (Nasdaq: CRVL ) ... broadcast live over the,Internet on Tuesday, August 5th at 11:30 am Eastern ... Earnings Release, Hosted by: Dan Starck, President and CEO ... Gordon Clemons, Chairman, Date: 11:30 ...
Cached Biology Technology:SEKAB Agreement: More Verified Ethanol to Europe 2Argonne researchers win 2 R&D 100 Awards 2Argonne researchers win 2 R&D 100 Awards 3Argonne researchers win 2 R&D 100 Awards 4CorVel Corporation Announces Earnings Release Webcast 2
(Date:9/18/2014)... devastated algal forests in the eastern Mediterranean Sea pose ... their distribution continues to expand as the climate warms, ... team of researchers led by Dr Adriana Vergs of ... Institute for Advanced Studies in Spain, is published in ... team surveyed more than 1000 kilometres of coastline in ...
(Date:9/18/2014)... that when people are too stressed they are often ... Brain Mind Institute (BMI) at EPFL have just highlighted ... chronic stress and the loss of social skills and ... a synaptic regulatory molecule in the brain. This was ... . , Carmen Sandi,s team went to look ...
(Date:9/18/2014)... research has found clownfish larvae can swim up to 400 ... able to cope with environmental change. , Clownfish spend their ... but as babies they must wander the open ocean, says ... Excellence for Coral Reef Studies (Coral CoE) at James Cook ... go, but now we,ve been given a rare glimpse into ...
Breaking Biology News(10 mins):Tropical fish a threat to Mediterranean Sea ecosystems 2How stress tears us apart 2Nemo's epic journey to find a new home 2
... The Smithsonian Tropical Research Institute will host the workshop ... August, 2008. , The event is sponsored by ... Committee of the Smithsonian National Board, and the Smithsonian ... scientists claim that up to half of all species ...
... Dickey Center for International Understanding, through its Institute ... million by the National Science Foundation through its ... The five-year grant supports the development ... sciences and engineering with a focus on rapid ...
... PASADENA, Calif.-- Individuals with synesthesia perceive the world in ... their senses are ,cross-activated, some synesthetes perceive numbers or ... as possessing personalities, even ,as they function normally in ... Technology have discovered a type of ,synesthesia in which ...
Cached Biology News:Dartmouth awarded NSF grant for new polar sciences, engineering grad program 2Dartmouth awarded NSF grant for new polar sciences, engineering grad program 3Caltech neurobiologists discover individuals who 'hear' movement 2Caltech neurobiologists discover individuals who 'hear' movement 3
Proteinase K Buffer 3.9 ml...
Rabbit polyclonal to hCG ( Abpromise for all tested applications). entrezGeneID: 1081 SwissProtID: P01215...
Anti-Indolamine (Indoleamine) 2,3-dioxygenase Immunogen: Recombinant human IDO. Available Date: 38454...
Glutathione Agarose Beads 10 ml...
Biology Products: